Publication Details

A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck.

Colevas AD, Adak S, Amrein PC, Barton JJ, Costello R, Posner MR. Ann Oncol. 2000; 11 (5): 535-9

A phase II study to determine the response rate and toxicity of docetaxel and 5-fluorouracil (5-FU) every four weeks ('TF'), in patients with incurable SCCHN.

PubMedID: 10907945